News

The application proposed the use of Genasense in combination with chemotherapy for treatment of patients with relapsed or refractory chronic lymphocytic leukemia (CLL). In a phase III trial

Zentase met all primary and secondary endpoints in two phase III trials. The studies were designed to determine whether the product candidate could alleviate serious malabsorption associated with

Campath is currently approved for the treatment of B-cell chronic lymphocytic leukemia (B-CLL) in patients who have been previously treated with an alkylating agent and have failed fludarabine

The application seeks approval to market the drug for the treatment of non-small cell lung cancer patients with brain metastases. The company received a refuse to file letter

Roche Diagnostics said the acquisition would allow it to expand its immunochemistry business from the human diagnostics field into new market segments such as life science research, life

The study clearly demonstrated a robust protective effect in mice treated with the synDNA vaccine whereas all the untreated control animals died after both groups were challenged with

The primary objectives of the trial are a partial or complete tumor response and stable disease. Secondary outcomes include progression-free survival and quality of life. The study will

The combination drug, known as Trexima, contains the treatments Imitrex and naproxen sodium, and is being developed by GlaxoSmithKline and Pozen. “Recent research suggests that migraine is more

Until recently all medicines were distributed through a number of competing wholesalers. However, in March 2007 Pfizer began selling prescription drugs solely through one wholesaler, Unichem, a division